Log in to save to my catalogue

Lactobacillus rhamnosus GG cell-free supernatant as a novel anti-cancer adjuvant

Lactobacillus rhamnosus GG cell-free supernatant as a novel anti-cancer adjuvant

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_495673a6b4d14813a8ab689af18fa307

Lactobacillus rhamnosus GG cell-free supernatant as a novel anti-cancer adjuvant

About this item

Full title

Lactobacillus rhamnosus GG cell-free supernatant as a novel anti-cancer adjuvant

Publisher

England: BioMed Central Ltd

Journal title

Journal of translational medicine, 2023-03, Vol.21 (1), p.195-17, Article 195

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Gut microbiota modulation has been demonstrated to be effective in protecting patients against detrimental effects of anti-cancer therapies, as well as to improve the efficacy of certain anti-cancer treatments. Among the most characterized probiotics, Lactobacillus rhamnosus GG (LGG) is currently utilized in clinics to alleviate diarrhea, mucositis...

Alternative Titles

Full title

Lactobacillus rhamnosus GG cell-free supernatant as a novel anti-cancer adjuvant

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_495673a6b4d14813a8ab689af18fa307

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_495673a6b4d14813a8ab689af18fa307

Other Identifiers

ISSN

1479-5876

E-ISSN

1479-5876

DOI

10.1186/s12967-023-04036-3

How to access this item